177 related articles for article (PubMed ID: 37596322)
21. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.
Clark PA; Iida M; Treisman DM; Kalluri H; Ezhilan S; Zorniak M; Wheeler DL; Kuo JS
Neoplasia; 2012 May; 14(5):420-8. PubMed ID: 22745588
[TBL] [Abstract][Full Text] [Related]
22. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
23. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
Hou J; Deng Q; Zhou J; Zou J; Zhang Y; Tan P; Zhang W; Cui H
Oncogene; 2017 Feb; 36(8):1134-1144. PubMed ID: 27546621
[TBL] [Abstract][Full Text] [Related]
24. A-kinase interacting protein 1 as a potential biomarker of advanced tumor features and increased recurrence risk in papillary thyroid carcinoma patients.
Zhang L; Tao H; Ke K; Ma C
J Clin Lab Anal; 2020 Oct; 34(10):e23452. PubMed ID: 32643206
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of A-kinase interacting protein 1 expression in various cancers: A meta-analysis based on the Chinese population.
Xue S; Zhang C; Xu J; Zhou C
Medicine (Baltimore); 2022 Jun; 101(25):e29203. PubMed ID: 35758348
[TBL] [Abstract][Full Text] [Related]
26. Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling.
Oh H; Hwang I; Jang JY; Wu L; Cao D; Yao J; Ying H; Li JY; Yao Y; Hu B; Wang Q; Zheng H; Paik J
Cancer Res; 2021 Mar; 81(6):1528-1539. PubMed ID: 33509942
[TBL] [Abstract][Full Text] [Related]
27. miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.
Yin D; Ogawa S; Kawamata N; Leiter A; Ham M; Li D; Doan NB; Said JW; Black KL; Phillip Koeffler H
Oncogene; 2013 Feb; 32(9):1155-63. PubMed ID: 22580610
[TBL] [Abstract][Full Text] [Related]
28. MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.
Dong Z; Zou J; Li J; Pang Y; Liu Y; Deng C; Chen F; Cui H
Cancer Med; 2019 Dec; 8(18):7793-7808. PubMed ID: 31691527
[TBL] [Abstract][Full Text] [Related]
29. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
[TBL] [Abstract][Full Text] [Related]
30. A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations.
Ho KT; Chen PF; Chuang JY; Gean PW; Hsueh YS
Life Sci; 2022 Jan; 288():120176. PubMed ID: 34848192
[TBL] [Abstract][Full Text] [Related]
31. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.
Liu X; Yue C; Shi L; Liu G; Cao Q; Shan Q; Wang Y; Chen X; Li H; Wang J; Gao S; Niu M; Yu R
J Cell Mol Med; 2020 Jul; 24(13):7550-7562. PubMed ID: 32452133
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
Rong Y; Belozerov VE; Tucker-Burden C; Chen G; Durden DL; Olson JJ; Van Meir EG; Mackman N; Brat DJ
Cancer Res; 2009 Mar; 69(6):2540-9. PubMed ID: 19276385
[TBL] [Abstract][Full Text] [Related]
34. A kinase interacting protein (AKIP1) is a key regulator of cardiac stress.
Sastri M; Haushalter KJ; Panneerselvam M; Chang P; Fridolfsson H; Finley JC; Ng D; Schilling JM; Miyanohara A; Day ME; Hakozaki H; Petrosyan S; Koller A; King CC; Darshi M; Blumenthal DK; Ali SS; Roth DM; Patel HH; Taylor SS
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):E387-96. PubMed ID: 23319652
[TBL] [Abstract][Full Text] [Related]
35. Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells.
Thuringer D; Hammann A; Benikhlef N; Fourmaux E; Bouchot A; Wettstein G; Solary E; Garrido C
J Biol Chem; 2011 Feb; 286(5):3418-28. PubMed ID: 21127066
[TBL] [Abstract][Full Text] [Related]
36. Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.
Kapoor GS; Zhan Y; Johnson GR; O'Rourke DM
Mol Cell Biol; 2004 Jan; 24(2):823-36. PubMed ID: 14701753
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Immunohistochemical Expression of MTAP and AKIP1 in IDH1 Mutant Astrocytoma.
Ahmed MM; Lateef MA; Elwan A; Fouad EM; Elsayed DH; Abdelnour HM; Abdullatif A
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3875-3882. PubMed ID: 38019246
[TBL] [Abstract][Full Text] [Related]
38. Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity.
Liu Y; Li Z; Zhang M; Zhou H; Wu X; Zhong J; Xiao F; Huang N; Yang X; Zeng R; Yang L; Xia Z; Zhang N
Neuro Oncol; 2021 May; 23(5):743-756. PubMed ID: 33325513
[TBL] [Abstract][Full Text] [Related]
39. EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma.
Martija AA; Krauß A; Bächle N; Doth L; Christians A; Krunic D; Schneider M; Helm D; Will R; Hartmann C; Herold-Mende C; von Deimling A; Pusch S
Acta Neuropathol Commun; 2023 Nov; 11(1):177. PubMed ID: 37936247
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of a kinase interacting protein 1 in tongue squamous cell carcinoma correlates with lymph node metastasis and poor overall survival.
Sun Y; Shi G; Ma C; Jiao J; Liu Y; Gao Q; Zhang X; Feng Q
Medicine (Baltimore); 2021 Apr; 100(14):e25278. PubMed ID: 33832094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
